Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

Abstract Levodopa is the standard long-term dopamine replacement therapy to treat Parkinson’s disease (PD) symptoms. With time, levodopa may induce debilitating dyskinesias (LID), the treatment of which represents a large clinically unmet need. However, time-to-LID onset varies between patients, ref...

ver descrição completa

Detalhes bibliográficos
Principais autores: Eva König, Alessandra Nicoletti, Cristian Pattaro, Grazia Annesi, Roberto Melotti, Alessandro Gialluisi, Christine Schwienbacher, Anne Picard, Hagen Blankenburg, Irene Pichler, Nicola Modugno, Marina Ciullo, Teresa Esposito, Francisco S. Domingues, Andrew A. Hicks, Mario Zappia, Peter P. Pramstaller
Formato: Artigo
Idioma:English
Publicado em: Nature Portfolio 2021-10-01
coleção:Scientific Reports
Acesso em linha:https://doi.org/10.1038/s41598-021-99393-8

Internet

https://doi.org/10.1038/s41598-021-99393-8

Registros relacionados